「estimate」の検索結果

Build a velocity-based release roadmap with risk buffers. Use when the user says "release plan", "when will we ship", "plan the next release", "map sprints to milestones", "estimate our release date", "how many sprints until done", or wants to translate a backlog into a delivery timeline - even if they don't say "release planning". Based on "Agile Estimating and Planning" by Mike Cohn (velocity, story points, cone of uncertainty, risk buffers).

日本語の概要は準備中です。原文の説明を表示しています。

Decompose large epics into sprint-ready sub-epics using 9 splitting patterns. Use this skill when: - A spec is approved and you need to break a large feature into estimable work items for engineering - You want to split an epic that is too large for a single sprint - You need sized sub-epics with story point estimates for sprint planning - You are preparing for engineering handoff and need to identify work packages

日本語の概要は準備中です。原文の説明を表示しています。

The art-route layer of the Forge skills. route_media.py is the one command that generates an image or an image-to-video clip - through the paid API of any provider whose key is configured (OpenAI, Google Gemini, xAI, BytePlus ModelArk, fal.ai; the configured key is the owner's consent), else through the user's own signed-in Codex or Grok CLI - and prints one JSON line with the route, artifact, sha256 and cost estimate; with no route it answers no-route (codeart2d is then the last resort). Also the capability check (forge_doctor), API key configuration, the spend ledger, resume and Codex image adoption. Use when a Forge skill sends a generation here, for the capability check, or when the user asks about keys, routes or spend. Not for planning, processing or QA of sprites, video frames or maps (generate2dsprite, video2dsprite, generate2dmap) or for code-drawn art (codeart2d).

日本語の概要は準備中です。原文の説明を表示しています。

Show real token usage and estimated savings for the current session. Reads directly from the Claude Code session log — no AI estimation. Triggers on /caveman-stats. Output is injected by the mode-tracker hook; the model itself does not compute the numbers.

日本語の概要は準備中です。原文の説明を表示しています。

PM (Project Manager / Scrum Master) agent. Reads BA and TechLead artifacts and produces sprint plan, task breakdown, and story point estimates. Creates one tracked todo/checklist item per sprint task for live pipeline tracking (FR-42). Part of the Virtual Team Skill pipeline.

日本語の概要は準備中です。原文の説明を表示しています。

PM (Project Manager / Scrum Master) agent. Reads BA and TechLead artifacts and produces sprint plan, task breakdown, and story point estimates. Creates one TodoWrite entry per sprint task for live pipeline tracking (FR-42). Part of the Virtual Team Skill pipeline.

日本語の概要は準備中です。原文の説明を表示しています。

Calculate ROI for AI-as-a-Service (managed AI agents). Estimates cost savings, efficiency gains, and payback period for deploying AI agents across business operations. Use when evaluating whether managed AI agents make financial sense for a company.

日本語の概要は準備中です。原文の説明を表示しています。

Breaks work into ordered tasks. Use when you have a spec or clear requirements and need to break work into implementable tasks. Use when a task feels too large to start, when you need to estimate scope, or when parallel work is possible.

日本語の概要は準備中です。原文の説明を表示しています。

Guides the agent through TRID tolerance compliance under 12 CFR § 1026.19(e)(3), comparing Closing Disclosure fees to Loan Estimate fees across zero, 10% cumulative, and unlimited tolerance categories. Use when reviewing a CD for tolerance variances, determining whether a revised LE is permitted, calculating cure amounts, or resolving post-closing tolerance violations.

日本語の概要は準備中です。原文の説明を表示しています。

China legal triage assistant. Input a contract, labor dispute facts, lawsuit-cost question, or draft legal document need; output risk checklist, cost estimate, evidence outline, or editable document skeleton. Boundary: preliminary legal information only, not a lawyer and not formal legal advice.

日本語の概要は準備中です。原文の説明を表示しています。

JIRA time tracking via jira-as: log work, worklogs, estimates, reports, bulk-log. Edit/delete confirms first (data loss). NOT sprint capacity (mk:jira-agile).

日本語の概要は準備中です。原文の説明を表示しています。

Pre-ticket Fibonacci sizing for a paste-mode batch of user stories. Default mode is advisory-only (writes a Story Sizing Report). Opt-in `--auto-create` delegates ticket creation to mk:jira-issue + mk:jira-collaborate with mandatory dry-run + single batch confirmation gate. NOT for single-ticket estimation (mk:jira-estimator); NOT for sprint capacity (mk:planning-engine).

日本語の概要は準備中です。原文の説明を表示しています。

Heuristic story-point estimation for a single Jira ticket via the jira-estimator agent. Read-only. Triggers: 'estimate KEY', 'story points for KEY', 'how complex is KEY'. NOT for complexity-only analysis (mk:jira-evaluator); NOT for full RCA (mk:jira-analyst).

日本語の概要は準備中です。原文の説明を表示しています。

Fast parallel codebase scouting. Spawns multiple Explore subagents to search directories simultaneously, returning a consolidated file map with architecture fingerprint, complexity estimates, and routing suggestions. Use before planning, debugging, or any task spanning multiple directories. NOT for reading a single known file in depth (use Read directly); NOT for semantic find-usages or go-to-definition.

日本語の概要は準備中です。原文の説明を表示しています。

Assigns confidence scores to agent outputs based on multiple factors including source quality, consistency, and reasoning depth. Produces calibrated confidence estimates. Activate on 'confidence score', 'how confident', 'certainty level', 'output confidence', 'reliability score'. NOT for validation (use dag-output-validator) or hallucination detection (use dag-hallucination-detector).

日本語の概要は準備中です。原文の説明を表示しています。

Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Estimates time-scaled phylogenies, molecular-clock rates, effective reproduction number R_e, and population dynamics from dated pathogen genomes using TreeTime (maximum-likelihood) and BEAST2 (Bayesian; strict/relaxed clocks; coalescent, Bayesian-Skyline, Skygrid, Birth-Death-Skyline, and sampled-ancestor priors; structured coalescent via MASCOT). Covers root-to-tip clock QC via TempEst, date-randomisation tests, recombination masking via Gubbins/ClonalFrameML before clock inference for recombining bacteria, BDSKY origin-vs-rootHeight pitfalls, sampling-bias correction, multi-chain convergence diagnostics, and reconciling phylodynamic R_e with case-based R_t. Use when dating outbreak origins, estimating substitution rates, inferring R_e through time, building time-calibrated Nextstrain Augur trees, choosing between strict and relaxed clocks, fitting Birth-Death-Skyline models, diagnosing temporal-signal failure, running MASCOT for structured-population analyses, or using UShER for pandemic-scale placement.

日本語の概要は準備中です。原文の説明を表示しています。

Estimate causal effects of an exposure on an outcome from GWAS summary statistics using genetic instruments. Implements IVW (fixed/random), MR-Egger, weighted median/mode, MR-RAPS, CAUSE, GSMR-HEIDI, MR-PRESSO, MVMR, MR-Clust, LCV, and LHC-MR via TwoSampleMR, MendelianRandomization, MR-PRESSO, cause, and lhcMR. Use when testing causal direction between traits, evaluating drug-target effects via cis-pQTL/cis-eQTL, performing multivariable mediation MR, distinguishing causation from correlated horizontal pleiotropy, or producing STROBE-MR-compliant sensitivity batteries.

日本語の概要は準備中です。原文の説明を表示しています。

Resolves GWAS associations to candidate causal variants and credible sets via SuSiE, susie_rss, FINEMAP, CAVIAR, DAP-G, PAINTOR, PolyFun, SuSiEx, MultiSuSiE, and FOCUS. Use when narrowing a GWAS lead SNP to a 95 percent credible set, choosing between in-sample and reference LD, calibrating non-sparse loci with SuSiE-inf or FINEMAP-inf, integrating functional priors via PolyFun, fine-mapping across ancestries with SuSiEx, diagnosing LD mismatch via estimate_s_rss and kriging_rss, handling HLA or long-range LD, or feeding credible sets into coloc.susie for colocalization.

日本語の概要は準備中です。原文の説明を表示しています。

Estimates bivariate genetic correlation (rg) between traits from GWAS summary statistics or individual-level genotypes using cross-trait LDSC, HDL, LAVA, rho-HESS, GREML-bivariate, Popcorn, and HDL-L. Use when quantifying shared genetic architecture between two traits, screening MR validity before causal inference, distinguishing global from locus-level rg, estimating trans-ancestry rg, separating partial from full causation via LCV gcp, or producing a STROBE-MR-compliant cross-trait sensitivity battery. Cross-trait LDSC intercept absorbs sample overlap and is NOT a bias; HDL is biased under sample overlap above ~5%. High rg between exposure and outcome motivates CHP-aware MR sensitivity (CAUSE, LHC-MR).

日本語の概要は準備中です。原文の説明を表示しています。

Detect and adjust for horizontal pleiotropy in two-sample Mendelian randomization by distinguishing uncorrelated (UHP) from correlated (CHP) pleiotropy and choosing among Egger, MR-PRESSO, MR-RAPS, CAUSE, LHC-MR, LCV, MR-Clust, MR-Mix, and contamination-mixture methods. Use when validating an MR causal claim, running the STROBE-MR sensitivity battery, suspecting a shared heritable confounder, working under weak-instrument or polygenic-exposure regimes, or reconciling discordant estimates across robust methods.

日本語の概要は準備中です。原文の説明を表示しています。

Infers genetic super-population ancestry from a 23andMe/AncestryDNA file and computes ancestry-stratified odds ratios with an exploratory Ancestry Elevation Score (AES) showing where ancestry-specific GWAS effect sizes diverge from European reference estimates.

日本語の概要は準備中です。原文の説明を表示しています。

Advises evaluating creatinine clearance or estimated glomerular filtration rate prior to intravenous bisphosphonate administration to guide dosing and ensure safety. Triggered when a clinician is planning to give zoledronic acid or pamidronate and asks about renal safety checks.

日本語の概要は準備中です。原文の説明を表示しています。

Calculate and interpret the PREVENT-ASCVD risk score (10-year and 30-year) for primary prevention of atherosclerotic cardiovascular disease per the 2026 ACC/AHA multisociety dyslipidaemia guideline. Covers inputs required, risk-category thresholds (low <3%, borderline 3–<5%, intermediate 5–<10%, high ≥10%), when to use the 30-year calculation (adults 30–59), and how PREVENT differs from the older Pooled Cohort Equations (lower risk estimates by 40–50%, race-agnostic). Use when a clinician asks what the 10-year ASCVD risk is, how to calculate PREVENT, PCE vs PREVENT, risk category for this patient, does my patient need a statin, 30-year risk calculation, primary prevention risk assessment. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.

日本語の概要は準備中です。原文の説明を表示しています。